Scientists are searching urgently for better ways to prevent and treat dementia as the number of people affected continues to rise around the world.
Dementia is not a single disease but a group of conditions that damage memory, thinking, behavior, and the ability to carry out everyday activities.
Experts estimate that around 55 million people currently live with dementia worldwide, and this number could grow to 139 million by the year 2050.
One of the most common forms of dementia is vascular dementia. This condition happens when blood flow to the brain becomes reduced or blocked, damaging brain cells over time.
Unlike Alzheimer’s disease, which is linked mainly to abnormal proteins building up in the brain, vascular dementia is strongly connected to problems with blood vessels and circulation.
People with vascular dementia may experience memory problems, confusion, difficulty concentrating, slower thinking, mood changes, and trouble planning or making decisions. The condition often develops after strokes or long-term damage to small blood vessels inside the brain.
Because poor blood flow plays such a major role in vascular dementia, scientists have become interested in medications that improve circulation. A recent study published in the journal Alzheimer’s & Dementia explored whether tadalafil, a drug commonly used to treat erectile dysfunction, could also help improve blood flow in the brain.
Tadalafil belongs to a group of medications called phosphodiesterase type 5 inhibitors, often shortened to PDE5 inhibitors. Other drugs in the same group include sildenafil, better known as Viagra, and vardenafil. These medications work by relaxing blood vessels, allowing blood to flow more easily through the body.
Doctors usually prescribe tadalafil for erectile dysfunction because improved blood flow helps support erections. The drug is also sometimes used to treat pulmonary hypertension, a condition involving high blood pressure in the lungs.
Over the years, researchers began to wonder whether drugs that improve blood flow in other parts of the body might also help the brain. Earlier studies had suggested that PDE5 inhibitors could possibly improve brain circulation and protect brain cells from damage.
Among these drugs, tadalafil appeared especially interesting because it stays in the body longer than similar medications. Scientists also believed it might reach the brain more effectively, making it a strong candidate for research into dementia treatment.
The recent study was a phase II clinical trial co-sponsored by the Alzheimer’s Drug Discovery Foundation in the United States and the Alzheimer’s Society in the United Kingdom. The researchers focused on older adults who had narrowed arteries in the brain, a condition that increases the risk of strokes and vascular dementia.
To study blood flow changes, researchers used a special type of MRI scan called arterial spin labeling. This advanced imaging method measures blood flow in the brain without the need for injections or radioactive substances. It allows scientists to safely observe circulation changes inside the brain.
Participants in the study received either a single dose of tadalafil or a placebo, which is a treatment with no active drug. The researchers then compared brain blood flow between the two groups.
Overall, the results did not show a major improvement in blood flow after a single dose of tadalafil. In general, there was no significant difference between the tadalafil group and the placebo group.
However, the researchers noticed something interesting when they looked more closely at participants over the age of 70. In these older adults, there appeared to be a small trend toward improved blood flow in an area of the brain called white matter.
White matter is extremely important because it helps different parts of the brain communicate with each other. Damage to white matter is common in vascular dementia and is strongly linked to memory and thinking problems.
Although the improvement was only slight and not strong enough to prove the drug works, the finding suggests tadalafil may still have potential worth exploring in future studies.
Another encouraging result was the drug’s safety profile. The researchers found no serious side effects among participants taking tadalafil. This is important because older adults are often more sensitive to medication side effects.
Dr. Jeremy Isaacs, one of the neurologists involved in the research, explained that a single dose may simply not be enough to produce clear benefits in the brain. He suggested that longer-term treatment studies may provide a better understanding of whether tadalafil could help slow or prevent vascular dementia.
Dr. Atticus Hainsworth, another member of the research team, said repurposing existing medications is a smart and practical strategy. Since tadalafil is already widely used and its safety profile is well understood, researchers may be able to move more quickly compared to developing an entirely new drug from scratch.
Creating new dementia drugs is extremely expensive and often takes many years. Many experimental treatments also fail during clinical trials. By testing medications that are already approved for other conditions, scientists hope to save time and reduce costs.
Katherine Gray from the Alzheimer’s Society also expressed cautious optimism about the findings. She said researchers are hopeful that future studies using different doses or longer treatment periods may reveal stronger benefits.
Although the study did not produce a major breakthrough, it has opened a new direction for dementia research. Scientists now have more reason to continue exploring how blood-flow-improving drugs may help protect the brain.
The study also highlights how medical discoveries can sometimes come from unexpected places. A medication originally developed for erectile dysfunction may one day play a role in protecting memory and brain function in older adults.
For now, experts stress that much more research is needed before tadalafil could be recommended as a treatment for vascular dementia. Future studies will need to test larger groups of patients over longer periods to determine whether the drug can truly improve brain health and slow disease progression.
Still, the findings offer hope at a time when dementia cases are rapidly increasing worldwide. As researchers continue searching for better treatments, familiar medicines like tadalafil may eventually provide surprising new tools in the fight against dementia.
If you care about brain health ,please read studies about Vitamin B9 deficiency linked to higher dementia risk, and cranberries could help boost memory.
For more health information, please see recent studies about heartburn drugs that could increase risk of dementia, and results showing this MIND diet may protect your cognitive function, prevent dementia.
The study was published in Alzheimer’s & Dementia.
Copyright © 2026 Knowridge Science Report. All rights reserved.
